Autoimmune gastritis (also called autoimmune atrophic gastritis) is a long-term immune-mediated condition affecting the lining of the stomach. It can reduce stomach acid and intrinsic factor, leading to iron deficiency and vitamin B12 deficiency. Diagnosis may involve blood tests and a gastroscopy with gastric mapping biopsies. Treatment replaces deficiencies, checks for Helicobacter pylori and plans endoscopic follow-up according to individual risk.
In brief: autoimmune gastritis is not cancer, and many people have few or no digestive symptoms. However, identifying and treating iron or vitamin B12 deficiency matters, and selected patients benefit from specialist endoscopic assessment or surveillance.
What is autoimmune gastritis?
Autoimmune gastritis develops when the immune system mistakenly targets parietal cells, which are concentrated in the body and upper part of the stomach. These cells normally make:
- stomach acid, which supports digestion and the absorption of some nutrients
- intrinsic factor, a protein needed to absorb vitamin B12
Over time, the stomach lining can become inflamed and thinner, a process called gastric atrophy. Reduced acid can impair iron absorption, while loss of intrinsic factor can cause vitamin B12 deficiency. The condition is also known as autoimmune atrophic gastritis, autoimmune metaplastic atrophic gastritis or type A gastritis.
Key facts about autoimmune gastritis
- It may cause no obvious digestive symptoms.
- Iron deficiency can develop before vitamin B12 deficiency.
- Pernicious anaemia is a possible later consequence, not another name for every case of autoimmune gastritis.
- A negative intrinsic factor antibody test does not rule it out.
- A positive parietal cell antibody test does not confirm the extent of stomach damage.
- Gastroscopy with correctly sited biopsies may be needed for diagnosis and risk assessment.
- The condition is associated with a higher risk of certain stomach tumours, but most people do not develop stomach cancer.
- Vitamin and iron deficiencies can usually be treated effectively.
What symptoms can autoimmune gastritis cause?
Some people have no symptoms, particularly early in the condition. When symptoms occur, they may reflect iron deficiency, vitamin B12 deficiency, anaemia or an overlapping digestive problem.
Symptoms of iron or vitamin B12 deficiency
- tiredness, weakness or reduced exercise tolerance
- breathlessness, palpitations or headaches
- difficulty concentrating or “brain fog”
- a sore or inflamed tongue
- pins and needles, numbness or altered sensation
- poor balance or unsteadiness
Vitamin B12 deficiency can affect the nervous system even when the haemoglobin and red-cell size are normal. New neurological symptoms should therefore be assessed promptly.
Possible digestive symptoms
- indigestion or upper abdominal discomfort
- nausea
- bloating
- feeling full soon after starting a meal
- reduced appetite
These symptoms are not specific to autoimmune gastritis and can have many causes. They should be interpreted alongside your history, examination and test results rather than attributed to one condition without assessment. Separate information is available about abdominal pain and heartburn and acid reflux.
Is autoimmune gastritis the same as pernicious anaemia?
No. Autoimmune gastritis is the underlying stomach condition. Pernicious anaemia is a possible later manifestation of severe vitamin B12 deficiency caused by loss of intrinsic factor.
A person may have autoimmune gastritis for years before vitamin B12 deficiency or anaemia develops. Iron deficiency may appear earlier because lower stomach acid can make iron harder to absorb. It is also possible to have vitamin B12 deficiency without anaemia or enlarged red blood cells.
NICE now uses the term autoimmune gastritis rather than using “pernicious anaemia” to describe the stomach condition, helping to keep the cause and its possible consequence distinct.
What causes autoimmune gastritis?
The exact cause is not fully understood. Genetic susceptibility, immune factors and environmental influences may all contribute. Autoimmune gastritis is seen more often alongside other autoimmune conditions, including:
- autoimmune thyroid disease
- type 1 diabetes
- vitiligo
- Addison’s disease
- coeliac disease
Having one of these conditions does not mean that autoimmune gastritis will necessarily develop. Your clinician may consider targeted testing for associated autoimmune disease when the history or results suggest it.
How is autoimmune gastritis diagnosed?
There is no single test that confirms or excludes autoimmune gastritis in every person. Diagnosis usually combines the clinical history, blood results and, where appropriate, gastroscopy and biopsy findings.
Blood tests for autoimmune gastritis
Tests may include:
- full blood count
- ferritin and iron studies
- vitamin B12 and folate
- intrinsic factor antibodies
- gastric parietal cell antibodies
- thyroid function tests
- coeliac blood tests when appropriate
- testing for H. pylori
- gastrin and sometimes pepsinogen tests in selected cases
A positive intrinsic factor antibody result strongly supports an autoimmune cause of vitamin B12 deficiency. The test is not positive in everyone with autoimmune gastritis, so a negative result does not completely exclude it.
Parietal cell antibodies are less specific. They may be present before established atrophy, can occur in people without autoimmune gastritis and may become less detectable later in the disease. Antibody results therefore need to be interpreted in context.
Gastroscopy and gastric mapping biopsies
During a gastroscopy (OGD or upper endoscopy), the gastroenterologist examines the oesophagus, stomach and duodenum with a thin flexible camera. Small tissue samples can be taken without causing pain.
When autoimmune or atrophic gastritis is suspected, high-quality examination and biopsies from defined areas help establish the pattern and extent of disease. Samples are commonly taken from the antrum and incisura, the body of the stomach and any visible abnormality, with samples labelled by site. This is often called gastric mapping.
Biopsies can show:
- corpus-predominant inflammation and gastric atrophy
- intestinal metaplasia
- H. pylori infection
- neuroendocrine cell changes
- dysplasia or cancerous change
Blood tests cannot show the amount or distribution of stomach-lining change. The biopsy report can therefore be important when deciding whether follow-up gastroscopy is appropriate.
Does everyone with positive antibodies need a gastroscopy?
Not necessarily. A positive antibody result on its own does not automatically mean that gastroscopy is required. The decision may take account of age, iron or vitamin B12 deficiency, evidence of pernicious anaemia, symptoms, family history of stomach cancer, H. pylori status and previous endoscopy findings.
NICE advises considering gastroscopy with a gastric body biopsy when autoimmune gastritis remains suspected despite negative intrinsic factor antibodies. New or worsening upper gastrointestinal symptoms in someone with suspected or confirmed autoimmune gastritis are also a reason to consider endoscopic assessment. The benefits and limitations should be discussed for the individual patient.
What complications can autoimmune gastritis cause?
Iron deficiency
Iron deficiency is common and may precede vitamin B12 deficiency. It should still be assessed carefully because menstrual blood loss, coeliac disease, dietary factors and bleeding from the stomach or bowel are other possible causes. Read more about the investigation and treatment of iron deficiency anaemia.
Vitamin B12 deficiency
Vitamin B12 deficiency can cause anaemia and neurological problems, including numbness, pins and needles, weakness, memory or concentration difficulty and impaired balance. Some nerve-related effects may become permanent if treatment is substantially delayed.
Type 1 gastric neuroendocrine tumours
Reduced stomach acid can lead to persistently raised gastrin. This may stimulate enterochromaffin-like cells in the stomach and, in a minority of people, lead to type 1 gastric neuroendocrine tumours. These tumours are often small and slow-growing, but they require specialist assessment, treatment where indicated and an appropriate follow-up plan.
Stomach cancer
Autoimmune gastritis is associated with a higher risk of gastric adenocarcinoma than in the general population. It is important to keep this in perspective: autoimmune gastritis is not cancer, and most people with the condition do not develop stomach cancer.
Individual risk may be influenced by the extent and severity of atrophy, intestinal metaplasia, dysplasia, age, smoking, a first-degree family history of stomach cancer, H. pylori infection and the quality of the baseline examination. These factors are considered when discussing stomach cancer risk assessment and surveillance.
How is autoimmune gastritis treated?
There is currently no established treatment that reliably reverses the autoimmune damage. Management focuses on correcting deficiencies, treating relevant infection, investigating symptoms and monitoring the stomach when the likely benefit outweighs the burden or risk.
Vitamin B12 replacement
For vitamin B12 deficiency caused, or suspected to be caused, by autoimmune gastritis, NICE recommends lifelong intramuscular vitamin B12 replacement. In the UK this is usually hydroxocobalamin. The initial and maintenance schedules depend on symptoms, the severity of deficiency and whether neurological features are present.
Treatment should not be unnecessarily delayed when there is severe anaemia or significant neurological involvement. The prescriber should advise the appropriate regimen; dietary supplements should not replace prescribed treatment.
Iron replacement
Iron deficiency may be treated with oral iron or intravenous iron. The choice depends on the degree of deficiency, symptoms, tolerance, response, absorption and whether there is another source of blood loss. Some people with autoimmune gastritis respond poorly to oral iron and may need intravenous replacement after individual assessment.
Testing for Helicobacter pylori
People with atrophic gastritis should be assessed for H. pylori. If the infection is present, eradication treatment should be offered and successful clearance confirmed with an appropriate non-serological test.
Diet and acid-reducing medication
No diet has been shown to reverse autoimmune gastritis or restore intrinsic factor. A balanced diet supports general health but cannot replace medically required vitamin B12 or iron treatment. People following several dietary restrictions may benefit from advice from a registered dietitian.
Autoimmune gastritis often lowers stomach acid rather than increasing it. Acid-reducing medication is therefore not automatically the right treatment for every upper-digestive symptom. However, a separate condition such as acid reflux may still require treatment. Do not stop prescribed medication without discussing it with the prescribing clinician.
Will I need surveillance gastroscopy?
Not every person needs the same schedule. The quality and findings of the first gastroscopy, the extent of atrophy or intestinal metaplasia, previous gastric polyps or neuroendocrine tumours, dysplasia, family history, H. pylori status, age, other health conditions and personal preferences all matter.
The 2025 European MAPS III guideline conditionally suggests high-quality endoscopic follow-up every three years for autoimmune gastritis. NICE does not set a routine surveillance interval; it advises considering endoscopy when new or worsening upper gastrointestinal symptoms occur. Because the evidence is limited and guidance differs, the interval should be agreed through shared decision-making after review of the original endoscopy report, photographs and biopsy results.
People with a previous gastric neuroendocrine tumour, dysplasia or another high-risk finding may need a different interval. Repeated procedures may offer little benefit for some people because of frailty, other illness or limited ability to undergo treatment if an abnormality were found.
When should I seek medical advice promptly?
Seek prompt medical assessment for:
- difficulty swallowing or food sticking
- persistent vomiting
- vomiting blood or passing black, tar-like stools
- unintentional weight loss or progressive loss of appetite
- persistent or worsening upper abdominal pain
- increasing breathlessness, palpitations or fainting
- new numbness, pins and needles, balance problems or confusion
These symptoms do not necessarily mean that a serious condition is present, but they should not be assumed to be due to autoimmune gastritis without assessment. Vomiting blood, black stools, severe breathlessness, collapse or rapidly worsening symptoms may require urgent or emergency care.
When may a gastroenterology consultation be helpful?
A specialist review may be useful if you have unexplained or recurrent iron deficiency, vitamin B12 deficiency, suspected pernicious anaemia, positive intrinsic factor or parietal cell antibodies, a biopsy report mentioning gastric atrophy or intestinal metaplasia, uncertainty about previous gastric mapping, or questions about surveillance.
During a consultation, symptoms, blood tests, medication, previous gastroscopy reports and biopsy findings can be considered together. Further investigation or treatment is recommended only when clinically appropriate; a consultation does not guarantee that a particular procedure or treatment will be advised.
Dr Udit Mittal, Consultant Gastroenterologist and Endoscopist, offers private consultations in Oxford, Banbury and Aylesbury. You can view the gastroenterology services, check consultation fees or contact the practice to request an appointment.
Frequently asked questions about autoimmune gastritis
Can autoimmune gastritis cause iron deficiency without anaemia?
Yes. Ferritin and iron stores may fall before haemoglobin does. Other causes of iron deficiency should still be considered rather than assuming autoimmune gastritis is responsible.
Can autoimmune gastritis cause vitamin B12 deficiency without anaemia?
Yes. Vitamin B12 deficiency can occur with a normal haemoglobin and normal red-cell size. Neurological symptoms such as numbness, pins and needles or balance difficulty need prompt assessment.
Does a positive parietal cell antibody confirm autoimmune gastritis?
No. It supports the possibility but does not show whether gastric atrophy is present or how extensive it is. The result should be considered alongside other blood tests and, when appropriate, stomach biopsies.
Does a negative intrinsic factor antibody rule it out?
No. NICE specifically advises that a negative result does not rule out autoimmune gastritis. Further tests may be appropriate when clinical suspicion remains.
Is autoimmune gastritis curable?
There is currently no established treatment that reliably reverses the autoimmune process. Iron and vitamin B12 deficiency can usually be treated, while risk-based monitoring can help detect relevant complications.
Is autoimmune gastritis cancer?
No. It is a chronic inflammatory and atrophic condition, not cancer. It is associated with a higher risk of gastric neuroendocrine tumours and possibly gastric adenocarcinoma, which is why selected patients are offered endoscopic follow-up.
Does everyone need a gastroscopy every year?
No. Annual gastroscopy is not routine for uncomplicated autoimmune gastritis. The interval depends on biopsy findings, previous tumours or polyps and the person’s wider risk profile.
Can diet replace vitamin B12 injections?
No. Diet cannot replace intrinsic factor or reliably correct vitamin B12 malabsorption caused by autoimmune gastritis. Prescribed replacement should be continued as advised.
Should family members be tested?
Routine testing of every family member is not usually necessary. A relative with unexplained iron deficiency, vitamin B12 deficiency or suggestive symptoms should discuss appropriate assessment with their own clinician.
Evidence and important information
This patient information reflects NICE guideline NG239 on vitamin B12 deficiency, British Society of Gastroenterology guidance on gastric cancer risk, and the 2025 European MAPS III guideline. Recommendations may change as evidence develops.
This page provides general information and is not a substitute for an individual medical consultation, examination, blood tests, gastroscopy or review of biopsy results. Treatment and surveillance decisions should be made with a suitably qualified clinician who knows your circumstances.
Last reviewed: 22 August 2026.